KRAS mutant cancer cells, being the progenitor of most pancreatic cancers 27, are defined by radical metabolic transformations to survive the hostile microenvironment, and treating them by exploiting such features has emerged as a fresh perspective that is worth trying 28. This evidence concerns the gene KRAS and familial pancreatic carcinoma.